Aible, known by its English name Aible, embodies the mission of empowering individuals with disabilities to reclaim their abilities through the use of AI technology. The company has ventured into the field of non-invasive brain-computer interface (BCI) rehabilitation, recognizing its immense market potential and capitalizing on the signal processing prowess of its parent company, iFLYTEK. Furthermore, Aible has forged a collaboration with Professor Chen Xun's team from the Advanced Technology Research Institute at the University of Science and Technology of China, establishing a joint laboratory to spearhead technological advancements.

Aible has prioritized rehabilitation as its initial application domain, with products primarily designed for patients recovering from strokes and spinal cord injuries. The company has developed a closed-loop intervention system termed "central-peripheral-central" to facilitate comprehensive rehabilitation. Presently, its lower limb walking rehabilitation training device has secured a medical device registration certificate and is already in clinical use.

Aible's core ambition is to achieve BCI-assisted rehabilitation that is "swifter, more precise, and more reliable." This is accomplished by minimizing latency through a streaming, lightweight, real-time decoding architecture and leveraging edge-side high-performance computing. Recognition accuracy is enhanced through the integration of joint blind source separation and deep learning algorithms for noise reduction. Stability is ensured via small-sample calibration, adaptive alignment, and rejection strategies tailored for universal decoding models.

In 2026, Aible is set to participate in a project at the Second People's Hospital of Anhui Province. This initiative will involve introducing its products into actual rehabilitation wards to gather feedback and data for ongoing product refinement. The project will also extend its scope to encompass attention, emotion, and cognition.

General Manager Su Ying, with her background in public health, adheres to the adage, "If it ain't broke, don't fix it," and is currently dedicated to perfecting products for rehabilitation settings. She underscores the significance of genuine clinical validation and the preservation of user dignity. Su Ying believes that technology should assist individuals in regaining specific abilities rather than striving for a homogenized "normal" state.